摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-2-硝基苄醇 | 22996-19-6

中文名称
4-溴-2-硝基苄醇
中文别名
2-硝基-4-溴苄醇;4-溴-2-硝基苄基醇
英文名称
(4-bromo-2-nitrophenyl)methanol
英文别名
4-bromo-2-nitrobenzyl alcohol
4-溴-2-硝基苄醇化学式
CAS
22996-19-6
化学式
C7H6BrNO3
mdl
——
分子量
232.034
InChiKey
VEVBVFGGMFKIBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    338.5±27.0 °C(Predicted)
  • 密度:
    1.767±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2906299090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    存放在室温、干燥且密封的环境中。

SDS

SDS:cff0368cc26dc6fd38ebe887c945e502
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromo-2-nitrobenzyl alcohol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-2-nitrobenzyl alcohol
CAS number: 22996-19-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6BrNO3
Molecular weight: 232

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

4-溴-2-硝基苄醇是一种醇类有机化合物,可作为有机合成的中间体。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴-2-硝基苄醇manganese(IV) oxide 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 以78%的产率得到4-溴-2-硝基苯甲醛
    参考文献:
    名称:
    [EN] QUINAZOLINES FOR PDK1 INHIBITION
    [FR] QUINAZOLINES POUR L'INHIBITION DE PDK1
    摘要:
    公开号:
    WO2007117607A3
  • 作为产物:
    描述:
    4-溴-2-硝基苯甲醛 在 sodium tetrahydroborate 作用下, 以 四氢呋喃 为溶剂, 反应 0.25h, 以80%的产率得到4-溴-2-硝基苄醇
    参考文献:
    名称:
    Debundling, selection and release of SWNTs using fluorene-based photocleavable polymers
    摘要:
    设计并合成了基于 9,9-二烷基芴骨架和邻硝基苯苄醚的可光分解聚合物,从而在甲苯中获得了稳定的(n,m)富集的半导体 SWNT 悬浮液。对悬浮液进行光照射可促使 SWNTs 沉淀,TEM 图像显示 SWNTs 紧密堆积,表明部分聚合物涂层已被去除。
    DOI:
    10.1039/c1cc11400j
点击查看最新优质反应信息

文献信息

  • [EN] FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1<br/>[FR] DÉRIVÉS DE 1,4-DIHYDRODIOXINE FUSIONNÉS À UTILISER EN TANT QU'INHIBITEURS DE FACTEUR DE TRANSCRIPTION 1 DU CHOC THERMIQUE
    申请人:CANCER REC TECH LTD
    公开号:WO2015049535A1
    公开(公告)日:2015-04-09
    The present invention relates to compounds of formula I wherein A1, A2 R4 and Q are as defined herein. The compounds of the present invention are inhibitors of heat shock factor 1 (HSF1). In particular, the present invention relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of these compounds, and to pharmaceutical compositions comprising them.
    本发明涉及式I的化合物,其中A1、A2、R4和Q如本文所定义。本发明的化合物是热休克因子1(HSF1)的抑制剂。具体来说,本发明涉及将这些化合物用作治疗和/或预防增殖性疾病,如癌症的治疗剂。本发明还涉及制备这些化合物的方法,以及包含它们的药物组合物。
  • Preparation of carbamates from amines and alcohols under mild conditions
    作者:David D'Addona、Christian G Bochet
    DOI:10.1016/s0040-4039(01)00991-1
    日期:2001.7
    The practical and mild preparation of carbamates in a two-component system is described. The smooth reaction of an alcohol with 1,1′-carbonyldiimidazole, followed by subsequent trapping with an amine represents a safe replacement for phosgene derivatives.
    描述了在两组分系统中实用且温和的氨基甲酸酯制备方法。醇与1,1'-羰基二咪唑的平滑反应,然后用胺进行捕集,代表着光气生物的安全替代品。
  • [EN] SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF<br/>[FR] 3-PHÉNYLQUINAZOLIN-4(3H)-ONES SUBSTITUÉS ET LEURS UTILISATIONS
    申请人:BAYER AG
    公开号:WO2019063704A1
    公开(公告)日:2019-04-04
    The present invention covers substituted 3-Phenylquinazolin-4(3H)-one compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of various inflammatory and fibrotic diseases of the respiratory tract and of the lungs as well as lung cancer, as a sole agent or in combination with other active ingredients.
    本发明涵盖了通式(I)所述和定义的取代3-苯基喹唑啉-4(3H)-酮化合物,制备该化合物的方法,用于制备该化合物的有用中间体化合物,包含该化合物的药物组合物和组合物,以及利用该化合物制造用于治疗或预防疾病的药物组合物的用途,特别是用于治疗和/或预防呼吸道和肺部的各种炎症性和纤维化疾病以及肺癌,作为唯一药剂或与其他活性成分组合使用。
  • Novel bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
    申请人:Ackermann Jean
    公开号:US20070191603A1
    公开(公告)日:2007-08-16
    The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
    这项发明涉及公式(I)的新异双环衍生物,其中R1、R2、R3、R4、R5、R6、V、W、X和Y的定义如描述和索赔中所述,以及其生理上可接受的盐和酯。这些化合物抑制L-CPT1,可用作药物。
  • Photocatalyst‐free Synthesis of Indazolones under CO <sub>2</sub> Atmosphere
    作者:Tianbao Yang、Huiai Lu、Renhua Qiu、Ling Hong、Shuang‐Feng Yin、Nobuaki Kambe
    DOI:10.1002/asia.201900306
    日期:2019.5.2
    A convenient photocatalystfree method for the synthesis of redox‐active 1,2‐dihydro‐3H‐indazol‐3‐one derivatives from (2‐nitroaryl)methanol and amines was developed. The reaction proceeded efficiently at room temperature by irradiation of UV light under CO2 atmosphere (1.0 atm, flow) without any photocatalysts or additives. This mild, operationally simple method shows wide functional tolerance. The
    开发了一种简便的无光催化剂方法,可从(2-硝基芳基)甲醇胺类合成氧化还原活性的1,2-二氢-3 H-吲唑-3-酮衍生物。在室温下,通过在无任何光催化剂或添加剂的情况下,通过在CO 2气氛(1.0 atm,流量)下照射紫外线,使反应有效地进行。这种温和,操作简单的方法显示出广泛的功能公差。由CO 2和胺原位形成的氨基甲酸酯被认为是该反应的关键。已发现通过本方法合成的某些化合物具有较高的抗癌活性,可降低癌细胞系HeLa,MCF-7和U87的活力。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫